Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly
February 9th, 2015
Synthesis of custom plasmids is labor and time consuming. This protocol describes the use of Gibson assembly cloning to reduce the work and duration of custom DNA cloning procedure. The protocol described also produces reliable tagged protein constructs for mammalian expression at similar cost to the traditional cut-and-paste DNA cloning.
Overview
This protocol outlines the use of Gibson assembly cloning to streamline the synthesis of custom plasmids, significantly reducing the time and labor involved in DNA cloning. It enables the creation of reliable tagged protein constructs for mammalian expression at a cost comparable to traditional methods.
Key Study Components
Area of Science
- Molecular Biology
- Genetic Engineering
- Protein Expression
Background
- Custom plasmid synthesis is traditionally labor-intensive.
- Gibson assembly allows for the parallel creation of plasmids.
- Tagged proteins are essential for studying protein function.
- Efficient cloning techniques are crucial for genetic research.
Purpose of Study
- To simplify the process of creating complex DNA constructs.
- To produce wild type and mutant plasmids simultaneously.
- To enhance the efficiency of plasmid assembly for mammalian expression.
Methods Used
- Designing overlapping primer sets for DNA assembly.
- Amplifying DNA templates via PCR.
- Purifying PCR products before assembly.
- Transforming competent E. coli with assembled plasmids.
Main Results
- Successful assembly of plasmids containing flag tagged CSTF 64 proteins.
- Verification of plasmid constructs through sequencing.
- Demonstration of parallel assembly advantages over traditional methods.
- Production of constructs under the regulation of the human elongation factor one alpha promoter.
Conclusions
- The Gibson assembly method significantly reduces cloning time.
- It allows for the efficient production of tagged protein constructs.
- This approach can be applied to various genetic engineering projects.
Frequently Asked Questions
Executive Industry Relevance
Rapid, parallel generation of customized plasmid vectors using Gibson assembly enables efficient production of tagged protein constructs for functional studies in mammalian systems. This approach addresses the bottleneck of promoter-driven expression stability and construct availability, supporting early discovery and target validation workflows. The method enhances predictive confidence and accelerates portfolio triage by reducing cloning cycle times and increasing construct reliability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rapid interrogation of gene function through customizable expression constructs.
- Facilitates mechanistic de-risking by supporting parallel wild-type and mutant protein studies.
- Improves predictive confidence in target validation by ensuring stable gene expression in stem cell models.
Screening & Assay Development
- Prepares validated expression vectors for downstream phenotypic or biochemical assays.
- Supports assay standardization by enabling reproducible construct generation with defined tags and promoters.
- Accelerates screening readiness by reducing construct assembly timelines.
Translational & Preclinical Research
- Aligns construct design with disease-relevant systems by enabling expression in mammalian stem cells.
- Supports continuity from discovery to preclinical validation through robust promoter-driven expression.
- Reduces risk of expression loss, supporting translational biomarker studies when relevant.
Pipeline & Workflow Integration
This Gibson assembly-based method integrates at the early discovery and assay development stages, bridging construct design to functional validation in mammalian systems.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling rapid construct generation for gene function studies.
- Screening: Provides assay-ready, reproducible plasmids with quantitative output potential.
- Analytics: Delivers sequence-verified constructs, supporting reliable comparison of wild-type and mutant protein effects.
- Translational Research: Facilitates expression in disease-relevant stem cell models, supporting preclinical continuity.
- Enterprise Reuse: Establishes a scalable, reusable workflow for future construct needs across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in gene function studies.
- Operational Value: Standardizes and accelerates construct generation with high reproducibility.
- Strategic Value: Enables faster go/no-go decisions and improves capital efficiency by shortening cloning cycles.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of validated targets.
Implementation Considerations
- Requires expertise in computational sequence design and primer generation tools.
- Needs access to PCR, DNA purification, and sequencing infrastructure.
- Demands cross-team standardization of construct design and verification steps.
- Adaptable to various model systems with appropriate promoter and tag selection.
- Dependent on availability of template DNAs and synthetic DNA fragment procurement timelines.
Biopharma FAQs
Chapters in this video
0:05
Title
1:30
In Silico Design: Final Plasmid and Overlapping Primers
3:58
Amplification of the DNA Fragments
5:44
DNA Purification Using Magnetic Beads
6:58
Assembly Cloning Reaction and Transformation of the Products in E. coli
8:21
Results: Cloning of CstF-54 and CstF-64 Mutants Under the Transcriptional Regulation of Human Elongation Factor 1α Promoter
9:47
Conclusion
